昇達科3491.TW Overview

昇達科（3491）Key Information

昇達科（3491）FAQ

• When is 3491's latest earnings report released?

  The most recent financial report for 昇達科 (3491) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 3491's short-term business performance and financial health. For the latest updates on 3491's earnings releases, visit this page regularly.

• Where does 3491 fall in the P/E River chart?

  According to historical valuation range analysis, 昇達科 (3491)'s current price-to-earnings (P/E) ratio is 50.93, placing it in the Overvalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

• What is the operating profit of 3491?

  According to the latest financial report, 昇達科 (3491) reported an Operating Profit of 84.03M with an Operating Margin of 17.37% this period, representing a decline of 54.7% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

• How is 3491's revenue growth?

  In the latest financial report, 昇達科 (3491) announced revenue of 483.91M, with a Year-Over-Year growth rate of -24.35%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

• How much cash does 3491 have?

  At the end of the period, 昇達科 (3491) held Total Cash and Cash Equivalents of 1.15B, accounting for 0.28 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

• Does 3491 go with three margins increasing?

  In the latest report, 昇達科 (3491) achieved the “three margins increasing” benchmark, with a gross margin of 47.31%%, operating margin of 17.37%%, and net margin of 18.24%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 3491's profit trajectory and future growth potential.

• Is 3491's EPS continuing to grow?

  According to the past four quarterly reports, 昇達科 (3491)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 1.33. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

• What is the FCF of 3491?

  昇達科 (3491)'s Free Cash Flow (FCF) for the period is -87.99M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 91.93% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.